Indeed, the presence of a CDKN2A homozygous deletion would now classify an IDH-mutant astrocytoma as WHO grade 4, even in the absence of microvascular proliferation or necrosis [11]. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).